查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678732

全球性行為感染自我檢測市場：市場規模、佔有率、趨勢分析（按應用和地區）、細分市場預測（2025-2030 年）

STD Self-Testing Market Size, Share & Trends Analysis Report By Application (CT/NG Testing, Syphilis Testing, HIV Testing), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

性行為感染傳染病自我檢測市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，全球性行為感染傳染病 (STD) 自我檢測市場預計到 2030 年將達到 19.8 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 8.75%。對隱私和便利性的不斷成長的需求是性行為感染自我檢測市場的主要驅動力。性傳染病的恥辱感和對保密的擔憂常常使人們不願意去診所，特別是在較小的社區或那些醫療保健有限的社區。自我檢測套組可以讓人們輕鬆地在家中進行檢測並進行私下檢測，而無需去診所。線上訂購測試的便利性和快速、可靠的結果極大地促進了自我測試解決方案的採用，尤其是在重視健康管理自主權和保密性的年輕群體中。隨著人們尋求更個人化和更​​輕鬆的醫療保健選擇，預計這一趨勢將繼續推動市場發展。

此外，性行為感染感染發生率的不斷上升預計將極大地推動性行為感染自我檢測市場的發展，因為這凸顯了對更容易獲得、更有效的解決方案的需求。隨著全球愛滋病毒、披衣菌感染、梅毒和淋病病例的增加，公共衛生系統越來越重視早期發現和預防策略。自我檢測套組提供了一種實用的解決方案，使個人可以私下進行檢測並快速獲得治療。人們越來越意識到定期進行性病檢測的重要性，加上在家中進行檢測的便利性，推動了這些產品的需求。隨著性行為感染傳染病的持續蔓延，對更快捷、更謹慎、更方便用戶使用的選擇的需求可能會推動自我檢測市場的進一步成長。

此外，多個國家政府的大力支持以及主要產業參與者對開發性傳染感染套件的策略性舉措正在推動市場成長。例如，伯內特研究所與 Atomo Diagnostics 公司共同開發了一種活動性梅毒快速檢測方法，由澳洲政府資助 244 萬美元，成為性行為感染自我檢測市場的主要市場驅動力。橫向流動測試使用指尖採血樣本和梅毒抗體檢測，提供了專業和家庭自我檢測選項，使測試更容易、更方便和更謹慎。這些快速、易於使用的診斷技術的創新正在加速套件的採用，有助於滿足對更快、更可靠的性病檢測解決方案的需求，從而推動更廣泛的市場成長。

性行為感染傳染病自我檢測市場：分析概述

  • 到 2024 年，CT/NG 檢測部分將成為性行為感染自我檢測市場中最大的收益部分。這是因為此類感染疾病在世界各地流行率很高。披衣菌感染和淋病是最常見的性行為感染傳染病，對快速、便捷的檢測有著巨大的需求。
  • 這些感染疾病的自我檢測套組的採用越來越多，再加上易於使用且準確的診斷解決方案，進一步加強了 CT/NG 領域在市場上的主導地位。
  • 由於對早期檢測和預防的需求不斷增加，預計預測期內愛滋病毒檢測領域將成長最快。隨著人們對愛滋病毒及其影響的認知不斷提高，越來越多的人開始尋求在家中謹慎、方便的選擇。
  • 此外，愛滋病毒快速自我檢測的進步和政府支持措施也促進了這一領域的快速成長。
  • 由於先進的醫療基礎設施、強大的宣傳活動以及消費者對便利的家庭檢測解決方案的需求不斷成長，預計北美將在 2024 年引領全球市場。該地區對早期檢測的關注，加上監管支援和技術創新，進一步推動了市場主導。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章。性行為感染傳染病自我檢測市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 性行為感染傳染病自我檢測市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章。性行為感染傳染病自我檢測市場：按應用進行的估計和趨勢分析

  • 性行為感染傳染病自我檢測市場：按應用分類的儀表板
  • 性行為感染傳染病自我檢測市場：按應用進行的變化分析
  • 性行為感染自我檢測市場按應用分類（以收益為準）
  • 沙眼披衣菌/淋病奈瑟菌 (CT/NG) 檢測
  • 梅毒檢測
  • HIV 檢測
  • 其他

第5章性行為感染傳染病自我檢測市場：按地區分類的估計和趨勢分析

  • 區域控制面板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 最新趨勢和影響分析：按主要製造商
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析（2024年）
    • OraSure Technologies, Inc.
    • Selfdiagnostics
    • Wondfo
    • bioLytical Laboratories
    • autotest VIH
    • Abbott
    • Visby Medical
    • PrivaPath Diagnostics（LetsGetChecked）
    • NOWDiagnostics
Product Code: GVR-4-68040-521-9

STD Self-Testing Market Growth & Trends:

The global STD self testing market size is expected to reach USD 1.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.75% from 2025 to 2030. The growing demand for privacy and convenience is a key driver for the STD self-testing market, as individuals seek more discreet and accessible ways to monitor their sexual health. Many people are hesitant to visit clinics due to the stigma associated with STDs and concerns about confidentiality, especially in smaller communities or regions with limited healthcare access. Self-test kits, which offer the convenience of being taken at home, allow users to test privately without the need for clinical visits. The ease of ordering tests online and receiving quick, reliable results has significantly contributed to adopting self-testing solutions, especially among younger populations who value autonomy and confidentiality in managing their health. This trend is expected to continue driving the market as individuals seek more personalized and hassle-free healthcare options.

In addition, the rising prevalence of STDs is expected to significantly drive the STD self-testing market, as increasing infection rates underscore the need for more accessible and efficient solutions. With cases of HIV, chlamydia, syphilis, and gonorrhea rising globally, public health systems are increasingly focused on early detection and prevention strategies. Self-testing kits offer a practical solution, enabling individuals to test in the privacy of their homes and seek treatment promptly. The growing awareness of the importance of regular STD testing, combined with the convenience of at-home diagnostics, is fueling demand for these products. As STDs continue to spread, the need for faster, discreet, and user-friendly options will drive further growth in the self-testing market.

Moreover, strong support from government of several countries and strategic initiatives undratken by industry's leading players to develop kits for STI's fuel the growth of the market. For instance, the collaboration between Burnet Institute and Atomo Diagnostics on the development of a rapid active syphilis test, backed by USD 2.44 million in funding from the Australian Government, highlights a key market driver for the STD self-testing market. This lateral flow test, which uses a finger prick blood sample and a syphilis antibody assay, offers both professional and at-home self-test options, making testing more accessible, convenient, and discreet. Such innovations in rapid and user-friendly diagnostic technologies are accelerating the adoption of kits, driving growth in the broader market by meeting the demand for quicker and more reliable STD test solutions.

STD Self-Testing Market Report Highlights:

  • In 2024, the CT/NG Testing segment was the largest revenue-generating sector of the STD self testing market. This is attributed to the high prevalence of these infections globally. Both Chlamydia and Gonorrhea are among the most commonly reported sexually transmitted infections, driving significant demand for rapid, accessible testing.
  • The increasing adoption of self-test kits for these infections, coupled with easy-to-use and accurate diagnostic solutions, further solidifies the dominance of the CT/NG segment in the market.
  • HIV Testing segment is expected to grow the fastest during the forecast period due to the rising demand for early detection and prevention. With increasing awareness about HIV and its impact, more people are seeking discreet, convenient options at home.
  • The advancement in rapid HIV self-tests and government-backed initiatives are also contributing to the segment's rapid growth, offering users quick, reliable results in a private setting.
  • The North American region is set to reign the global market in the year 2024 due to advanced healthcare infrastructure, strong awareness campaigns, and increasing consumer demand for convenient, at-home test solutions. The region's focus on early detection, coupled with regulatory support and innovation, further drives its market leadership.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. STD Self Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising STD prevalence
      • 3.2.1.2. Advancements in rapid diagnostic technology
      • 3.2.1.3. Supportive regulatory approvals & government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and accessibility
  • 3.3. STD Self Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape

Chapter 4. STD Self Testing Market: Application Estimates & Trend Analysis

  • 4.1. Global STD Self Testing Market: Application Dashboard
  • 4.2. Global STD Self Testing Market: Application Movement Analysis
  • 4.3. Global STD Self Testing Market by Application , Revenue
  • 4.4. CT/NG Testing
    • 4.4.1. CT/NG testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Syphilis Testing
    • 4.5.1. Syphilis testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. HIV Testing
    • 4.6.1. HIV testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. STD Self Testing Market: Regional Estimates & Trend Analysis by Application and End Use

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. OraSure Technologies, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Selfdiagnostics
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Wondfo
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. bioLytical Laboratories
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. autotest VIH
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Abbott
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Visby Medical
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. PrivaPath Diagnostics (LetsGetChecked)
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. NOWDiagnostics
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 4 Global STD Self Testing, by Region, 2018 - 2030 (USD Billion)
  • Table 5 North America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 6 North America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 7 U.S. STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 8 Canada STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 9 Mexico STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 10 Europe STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 11 Europe STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 12 Germany STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 13 UK STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 14 France STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 15 Italy STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Spain STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 17 Denmark STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 18 Sweden STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 19 Norway STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 22 China STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 23 Japan STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 24 India STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 25 South Korea STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 26 Australia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 27 Thailand STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 28 Latin America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 30 Brazil STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 31 Argentina STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 34 South Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 36 UAE STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait STD Self Testing, by Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 STD Self Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global STD Self Testing Market, for Application, 2018 - 2030 (USD Billion)
  • Fig. 16 Global STD Self Testing Market, for CT/NG Testing, 2018 - 2030 (USD Billion)
  • Fig. 17 Global STD Self Testing Market, for Syphilis Testing, 2018 - 2030 (USD Billion)
  • Fig. 18 Global STD Self Testing Market, for HIV Testing, 2018 - 2030 (USD Billion)
  • Fig. 19 Global STD Self Testing Market, for Others, 2018 - 2030 (USD Billion)
  • Fig. 20 Regional Marketplace: Key Takeaways
  • Fig. 21 Regional Outlook, 2024 & 2030
  • Fig. 22 Global STD Self Testing Market: Region Movement Analysis
  • Fig. 23 North America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Mexico STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 30 France STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 38 China STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 39 India STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait STD Self Testing Market, 2018 - 2030 (USD Billion)